Analysis of protective immune responses to seasonal influenza vaccination in HIV-infected individuals

References

• Kaplan JE, Benson C.et al. Guidelines for prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America.MMWR Recomm Rep. 2009;58(RR-4):1-207.
   Google Scholar
• Tasker SA, Treanor JJ, Paxton WB, Wallace MR. Efficacy of influenza vaccination in HIV-infected persons: a randomized, double-blind, placebo-controlled trial. Ann Intern Med. 1999;131(6):430–33. doi:10.7326/0003-4819-131-6-199909210-00006.
   PubMed Web of Science ®Google Scholar
• Fowke KR, DʼAmico R, Chernoff DN, Pottage JC, Benson CA, Sha BE, Kessler HA, Landay AL, Shearer GM. Immunologic and virologic evaluation after influenza vaccination of HIV-1-infected patients. Aids. 1997;11(8):1013–21. doi:10.1097/00002030-199708000-00010.
   PubMed Web of Science ®Google Scholar
• Mallajosyula VV, Citron M, Ferrara F, Lu X, Callahan C, Heidecker GJ, Sarma SP, Flynn JA, Temperton NJ, Liang X, et al. Influenza hemagglutinin stem-fragment immunogen elicits broadly neutralizing antibodies and confers heterologous protection. Proc Nat Acad Sci. 2014;111(25):E2514–E2523. doi:10.1073/pnas.1402766111.
   PubMed Web of Science ®Google Scholar
• Wei C-J, Yassine HM, McTamney PM, Gall JGD, Whittle JRR, Boyington JC, Nabel GJ. Elicitation of broadly neutralizing influenza antibodies in animals with previous influenza exposure. Sci Transl Med. 2012;4(147):147ra114–147ra114. doi:10.1126/scitranslmed.3004273.
   PubMed Web of Science ®Google Scholar
• Yu X, Tsibane T, McGraw PA, House FS, Keefer CJ, Hicar MD, Tumpey TM, Pappas C, Perrone LA, Martinez O, et al. Neutralizing antibodies derived from the B cells of 1918 influenza pandemic survivors. Nature. 2008;455(7212):532–36. doi:10.1038/nature07231.
   PubMed Web of Science ®Google Scholar
• Itoh Y, Yoshida R, Shichinohe S, Higuchi M, Ishigaki H, Nakayama M, Pham VL, Ishida H, Kitano M, Arikata M, et al. Protective efficacy of passive immunization with monoclonal antibodies in animal models of H5N1 highly pathogenic avian influenza virus infection. PLoS Pathog. 2014;10(6):e1004192. doi:10.1371/journal.ppat.1004192.
   PubMed Web of Science ®Google Scholar
• DiLillo DJ, Tan GS, Palese P, Ravetch JV. Broadly neutralizing hemagglutinin stalk–specific antibodies require FcγR interactions for protection against influenza virus in vivo. Nat Med. 2014;20(2):143. doi:10.1038/nm.3443.
   PubMed Web of Science ®Google Scholar
• Rajão DS, Pérez DR. Universal vaccines and vaccine platforms to protect against influenza viruses in humans and agriculture. Front Microbiol. 2018;9:123. doi:10.3389/fmicb.2018.00123.
   PubMed Web of Science ®Google Scholar
• Wikramaratna PS, Sandeman M, Recker M, Gupta S. The antigenic evolution of influenza: drift or thrift? Philos Trans R Soc B. 2013;368(1614):20120200. doi:10.1098/rstb.2012.0200.
   PubMed Web of Science ®Google Scholar
• Sautto GA, Kirchenbaum GA, Ross TM. Towards a universal influenza vaccine: different approaches for one goal. Virol J. 2018;15(1):17. doi:10.1186/s12985-017-0918-y.
   PubMedGoogle Scholar
• Minton K. B cell memory: a second chance for antibodies. Nat Rev Immunol. 2015;15(3):131–131. doi:10.1038/nri3829.
   PubMed Web of Science ®Google Scholar
• Victora GD, Nussenzweig MC. Germinal centers. Annu Rev Immunol. 2012;30:429–57. doi:10.1146/annurev-immunol-020711-075032.
   PubMed Web of Science ®Google Scholar
• Lederman MM, Calabrese L, Funderburg NT, Clagett B, Medvik K, Bonilla H, Gripshover B, Salata RA, Taege A, Lisgaris M, et al. Immunologic failure despite suppressive antiretroviral therapy is related to activation and turnover of memory CD4 cells. J Infect Dis. 2011;204:1217–26. doi:10.1093/infdis/jir507.
   PubMed Web of Science ®Google Scholar
• Luo Z, Li M, Wu Y, Meng Z, Martin L, Zhang L, Ogunrinde E, Zhou Z, Qin S, Wan Z, et al. Systemic translocation of Staphylococcus drives autoantibody production in HIV disease. Microbiome. 2019;7(1):25. doi:10.1186/s40168-019-0646-1.
   PubMedGoogle Scholar
• Powell AM, Luo Z, Martin L, Wan Z, Ma L, Liao G, Song Y, Li X, Michael Kilby J, Huang L, et al. The induction of CD80 and apoptosis on B cells and CD40L in CD4+ T cells in response to seasonal influenza vaccination distinguishes responders versus non-responders in healthy controls and aviremic ART-treated HIV-infected individuals. Vaccine. 2017;35(5):831–41. doi:10.1016/j.vaccine.2016.12.026.
   PubMed Web of Science ®Google Scholar
• Luo Z, Ma L, Zhang L, Martin L, et al. Key differences in B cell activation patterns and immune correlates among treated HIV-infected patients versus healthy controls following influenza vaccination. Vaccine. 2016;34:1945–1955.
   PubMed Web of Science ®Google Scholar
• WHO. Manual for the laboratory diagnosis and virological surveillance of influenza.WHO Global Influenza Surveillance Network; 2011.
   Google Scholar
• Smyth GK, Speed T. Normalization of cDNA microarray data. Methods. 2003;31(4):265–73. doi:10.1016/S1046-2023(03)00155-5.
   PubMed Web of Science ®Google Scholar
• Wrammert J, Smith K, Miller J, Langley WA, Kokko K, Larsen C, Zheng N-Y, Mays I, Garman L, Helms C, et al. Rapid cloning of high-affinity human monoclonal antibodies against influenza virus. Nature. 2008;453(7195):667–71. doi:10.1038/nature06890.
   PubMed Web of Science ®Google Scholar
• Nayak JL, Fitzgerald TF, Richards KA, Yang H, Treanor JJ, Sant AJ. CD4+ T-cell expansion predicts neutralizing antibody responses to monovalent, inactivated 2009 pandemic influenza A (H1N1) virus subtype H1N1 vaccine. J Infect Dis. 2012;207(2):297–305. doi:10.1093/infdis/jis684.
   PubMed Web of Science ®Google Scholar
• Malkin E, Yogev R, Abughali N, Sliman J, Wang CK, Zuo F, Yang C-F, Eickhoff M, Esser MT, Tang RS, et al. Safety and immunogenicity of a live attenuated RSV vaccine in healthy RSV-seronegative children 5 to 24 months of age. PLoS One. 2013;8(10):e77104. doi:10.1371/journal.pone.0077104.
   PubMed Web of Science ®Google Scholar
• Chang Y-T, Guo C-Y, Tsai M-S, Cheng -Y-Y, Lin M-T, Chen C-H, Shen D, Wang J-R, Sung J-M. Poor immune response to a standard single dose non-adjuvanted vaccination against 2009 pandemic H1N1 influenza virus A in the adult and elder hemodialysis patients. Vaccine. 2012;30(33):5009–18. doi:10.1016/j.vaccine.2012.05.016.
   PubMed Web of Science ®Google Scholar
• Perreau M, Savoye AL, De Crignis E, Corpataux JM, Cubas R, Haddad EK, De Leval L, Graziosi C, Pantaleo G. Follicular helper T cells serve as the major CD4 T cell compartment for HIV-1 infection, replication, and production. J Exp Med. 2013;210(1):143–56. doi:10.1084/jem.20121932.
   PubMed Web of Science ®Google Scholar
• Lindqvist M, van Lunzen J, Soghoian DZ, Kuhl BD, Ranasinghe S, Kranias G, Flanders MD, Cutler S, Yudanin N, Muller MI, et al. Expansion of HIV-speci c T follicular helper cells in chronic HIV infection. J Clin Invest. 2012;122(9):3271–80. doi:10.1172/JCI64314.
   PubMed Web of Science ®Google Scholar
• Herati RS, Reuter MA, Dol DV, Mans Eld KD, Aung H, Badwan OZ, Kurupati RK, Kannan S, Ertl H, Schmader KE, et al. Circulating CXCR5+PD-1+ response predicts influenza vaccine antibody responses in young adults but not elderly adults. J Immunol. 2014;193(7):3528–37. doi:10.4049/jimmunol.1302503.
   PubMed Web of Science ®Google Scholar
• Boswell KL, Paris R, Boritz E, Ambrozak D, Yamamoto T, Darko S, Wloka K, Wheatley A, Narpala S, McDermott A, et al. Loss of circulating CD4 T cells with B cell helper function during chronic HIV infection. PLoS Pathog. 2014;10(1):e1003853. doi:10.1371/journal.ppat.1003853.
   PubMed Web of Science ®Google Scholar
• Pallikkuth S, Fischl MA, Pahwa S. Combination antiretroviral therapy with raltegravir leads to rapid immunologic reconstitution in treatment-naive patients with chronic HIV infection. J Infect Dis. 2013;208(10):1613–23. doi:10.1093/infdis/jit387.
   PubMed Web of Science ®Google Scholar
• Cubas R, van Grevenynghe J, Wills S, Kardava L, Santich BH, Buckner CM, Muir R, Tardif V, Nichols C, Procopio F, et al. Reversible reprogramming of circulating memory T follicular helper cell function during chronic HIV infection. J Immunol. 2015;195(12):5625–36. doi:10.4049/jimmunol.1501524.
   PubMed Web of Science ®Google Scholar
• Cohen K, Altfeld M, Alter G, Stamatatos L. Early preservation of CXCR5+ PD-1+ helper T cells and B cell activation predict the breadth of neutral- izing antibody responses in chronic HIV-1 infection. J Virol. 2014;88(22):13310–21. doi:10.1128/JVI.02186-14.
   PubMed Web of Science ®Google Scholar
• Moysi E, Pallikkuth S, De Armas LR, Gonzalez LE, Ambrozak D, George V, Huddleston D, Pahwa R, Koup RA, Petrovas C, et al. Altered immune cell follicular dynamics in HIV infection following influenza vaccination. J Clin Invest. 2018;128(7):3171–85. doi:10.1172/JCI99884.
   PubMed Web of Science ®Google Scholar
• Pallikkuth S, Pilakka Kanthikeel S, Silva SY, Fischl M, Pahwa R, Pahwa S. Upregulation of IL-21 receptor on B cells and IL-21 secretion distin- guishes novel 2009 H1N1 vaccine responders from nonresponders among HIV-infected persons on combination antiretroviral therapy. J Immunol. 2011;186(11):6173–81. doi:10.4049/jimmunol.1100264.
   PubMed Web of Science ®Google Scholar
• de Armas LR, Cotugno N, Pallikkuth S, Pan L, Rinaldi S, Sanchez MC, Gonzalez L, Cagigi A, Rossi P, Palma P, et al. Induction of IL21 in peripheral T follicular helper cells is an indicator of influenza vaccine response in a previously vaccinated HIV-infected pediatric cohort. J Immunol. 2017;198(5):1995–2005. doi:10.4049/jimmunol.1601425.
   PubMed Web of Science ®Google Scholar
• Breer H, Boekhoff I, Tareilus E. Rapid kinetics of second messenger formation in olfactory transduction. Nature. 1990;345(6270):65. doi:10.1038/345065a0.
   PubMed Web of Science ®Google Scholar
• Beavo JA, Brunton LL. Cyclic nucleotide research—still expanding after half a century. Nat Rev Mol Cell Biol. 2002;3(9):710. doi:10.1038/nrm911.
   PubMed Web of Science ®Google Scholar
• Gilbert K, Hoffmann M. cAMP is an essential signal in the induction of antibody production by B cells but inhibits helper function of T cells. J Immunol. 1985;135:2084–89.
   PubMed Web of Science ®Google Scholar
• Brenchley JM, Price DA, Schacker TW, Asher TE, Silvestri G, Rao S, Kazzaz Z, Bornstein E, Lambotte O, Altmann D, et al. Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nat Med. 2006;12(12):1365. doi:10.1038/nm1511.
   PubMed Web of Science ®Google Scholar
• Sewankambo N, Gray RH, Wawer MJ, Paxton L, McNairn D, Wabwire-Mangen F, Serwadda D, Li C, Kiwanuka N, Hillier SL, et al. HIV-1 infection associated with abnormal vaginal flora morphology and bacterial vaginosis. Lancet. 1997;350(9077):546–50. doi:10.1016/S0140-6736(97)01063-5.
   PubMed Web of Science ®Google Scholar
• Selwyn PA, Feingold AR, Hartel D, Schoenbaum EE, Alderman MH, Klein RS, Friedland GH. Increased risk of bacterial pneumonia in HIV-infected intravenous drug users without AIDS. AIDS. 1988;2(4):267–72. doi:10.1097/00002030-198808000-00005.
   PubMed Web of Science ®Google Scholar